MORGAN STANLEY - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$674
-31.7%
1210.0%0.00%
Q2 2023$987
-17.8%
121
-29.2%
0.00%
Q1 2023$1,200
-16.0%
1710.0%0.00%
Q4 2022$1,428
+42.8%
171
-1.2%
0.00%
Q3 2022$1,000173
+246.0%
0.00%
Q2 2022$0
-100.0%
50
-80.0%
0.00%
Q1 2022$3,000
-75.0%
250
-65.3%
0.00%
Q4 2021$12,000
+1100.0%
721
+1342.0%
0.00%
Q3 2021$1,000
-66.7%
50
-66.7%
0.00%
Q2 2021$3,0001500.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q1 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 597,662$6,837,00011.05%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 444,444$4,987,0000.88%
VILLERE ST DENIS J & CO LLC 265,997$2,984,0000.18%
FNY Investment Advisers, LLC 5,000$57,0000.05%
BENJAMIN F. EDWARDS & COMPANY, INC. 75,270$861,0000.04%
ARK Investment Management 228,657$2,566,0000.01%
BROWN ADVISORY INC 77,349$868,0000.00%
UBS Group AG 3,429$38,0000.00%
OSAIC HOLDINGS, INC. 248$3,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,600$40,0000.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders